Notes in NI.Q01-03.C001-NI.Q01-03.C010

To Subscribe, use this Key

Status	Last Update	Fields
Published	12/18/2023	In the context of multiple sclerosis, a relapse is the occurrence of new or increasing neurological symptoms persisting for {{c1::…
Published	12/18/2023	What differentiates a Clinically Isolated Syndrome (of demyelination) from multiple sclerosis?{{c1::lack of para-clinical evidence i.e. no new an…
Published	12/18/2023	Initial work-up of multiple sclerosis should rule out {{c1::vitamin B12 deficiency::nutrient deficiency}}.
Published	12/18/2023	Primary progressive multiple sclerosis is associated with {{c1::lower::higher/lower/equal}} MRI lesion burden compared to relapsing-remitting mul…
Published	12/18/2023	In the context of relapsing-remitting multiple sclerosis, remission is a {{c1::period without clinical progression}}.
Published	12/18/2023	What subtype of multiple sclerosis is characterized by rapidly progressive clinical deterioration and recurrent relapses?{{c1::Fulminant mul…
Published	12/18/2023	Patients with multiple sclerosis may have what CSF cell count abnormality?{{c1::mild lymphocytic pleocytosis}}
Published	12/18/2023	Patients with multiple sclerosis may have what CSF markers of immune activity?{{c1::(1) elevated IgG synthesis rate (2) elevated kappa …
Published	12/18/2023	Evoked potential tests in patients with multiple sclerosis will show {{c1::slowing (i.e. increased latency)}} which indicates {{c2::central demyelinat…
Published	12/18/2023	In relapsing-remitting multiple sclerosis, new lesions on MRI may develop during {{c1::both relapses and remissions::relapses/remissions}}.
Status	Last Update	Fields